National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
S Afr Med J. 2013 Mar 15;103(6):377-81. doi: 10.7196/samj.6722.
Patients with community-acquired urinary tract infections (UTIs) frequently present to healthcare facilities in South Africa (SA).
To provide information on UTI aetiology and antimicrobial susceptibility of pathogens.
We recruited women with UTI-related symptoms, who tested positive for ≥2 urine dipstick criteria (proteinuria, blood, leucocytes or nitrites) at 1 public and 5 private primary healthcare facilities in 2011. Demographic and clinical data were recorded and mid-stream urine (MSU) specimens were cultured. UTI pathogens were Gram-stained and identified to species level. Etest-based antimicrobial susceptibility testing was performed for amoxicillin/clavulanic acid, cefixime, cefuroxime, ciprofloxacin, fosfomycin, levofloxacin, nitrofurantoin, norfloxacin and trimethoprim/sulphamethoxazole.
Of the 460 women recruited, 425 MSU samples were processed and 204 UTI pathogens were identified in 201 samples. Most pathogens were Gram-negative bacilli (GNB) (182; 89.2%) and 22 (10.8%) were Gram-positive cocci (GPC). Escherichia coli was the most frequent GNB (160; 79.6%), while Enterococcus faecalis was the predominant GPC (8; 4.0%). The UTI pathogens had similar susceptibility profiles for fosfomycin (95.5%; 95% confidence interval (CI) 92.6 - 98.4), the 3 fluoroquinolones (94.1%; 95% CI 90.8 - 97.4), nitrofurantoin (91.7%; 95% CI 87.8 - 95.6), cefuroxime (90.1%; 95% CI 86.0 - 94.3) and cefixime (88.2%; 95% CI 83.7 - 92.6). UTI pathogens were less susceptible to amoxicillin/clavulanic acid (82.8%; 95% CI 77.5 - 88.0) when compared with fluoroquinolones and fosfomycin. Trimethoprim/ sulphamethoxazole was the least efficacious antimicrobial agent (44.3% susceptible; 95% CI 37.4 - 51.2).
This study provides relevant data for the empirical treatment of community-acquired UTIs in SA.
在南非,患有社区获得性尿路感染(UTI)的患者经常到医疗机构就诊。
提供有关 UTI 病因和病原体对抗菌药物敏感性的信息。
我们招募了有 UTI 相关症状的女性患者,她们在 2011 年在 1 家公立和 5 家私人初级保健机构中,通过 2 项尿液试纸检测(蛋白尿、血液、白细胞或亚硝酸盐)呈阳性。记录人口统计学和临床数据,并采集中段尿液(MSU)标本进行培养。对 UTI 病原体进行革兰氏染色并鉴定到种属水平。采用 Etest 法进行阿莫西林/克拉维酸、头孢克肟、头孢呋辛、环丙沙星、磷霉素、左氧氟沙星、呋喃妥因、诺氟沙星和复方磺胺甲噁唑的抗菌药物敏感性试验。
在招募的 460 名女性中,处理了 425 份 MSU 样本,在 201 份样本中鉴定出 204 种 UTI 病原体。大多数病原体为革兰氏阴性杆菌(GNB)(182;89.2%),22 种为革兰氏阳性球菌(GPC)(10.8%)。大肠埃希菌是最常见的 GNB(160;79.6%),而粪肠球菌是最主要的 GPC(8;4.0%)。UTI 病原体对磷霉素(95.5%;95%置信区间(CI)92.6-98.4)、3 种氟喹诺酮类药物(94.1%;95%CI 90.8-97.4)、呋喃妥因(91.7%;95%CI 87.8-95.6)、头孢呋辛(90.1%;95%CI 86.0-94.3)和头孢克肟(88.2%;95%CI 83.7-92.6)的敏感性相似。与氟喹诺酮类药物和磷霉素相比,UTI 病原体对抗阿莫西林/克拉维酸的敏感性较低(82.8%;95%CI 77.5-88.0)。复方磺胺甲噁唑是最无效的抗菌药物(44.3%敏感;95%CI 37.4-51.2)。
本研究为南非社区获得性 UTI 的经验性治疗提供了相关数据。